|
CENPJ expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.33030031435055E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.43649561532311E-11 |
| Normal-vs-Stage2 |
4.222300E-04 |
| Normal-vs-Stage3 |
6.07539999999407E-05 |
| Normal-vs-Stage4 |
5.540800E-03 |
| Stage1-vs-Stage2 |
7.540000E-01 |
| Stage1-vs-Stage3 |
6.653900E-02 |
| Stage1-vs-Stage4 |
7.123000E-01 |
| Stage2-vs-Stage3 |
3.576800E-01 |
| Stage2-vs-Stage4 |
6.288800E-01 |
| Stage3-vs-Stage4 |
2.807800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.45750000746636E-10 |
| Normal-vs-AfricanAmerican |
5.608200E-04 |
| Normal-vs-Asian |
4.799500E-02 |
| Caucasian-vs-AfricanAmerican |
9.283600E-01 |
| Caucasian-vs-Asian |
1.605800E-01 |
| AfricanAmerican-vs-Asian |
1.710570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.92050000347166E-08 |
| Normal-vs-Female |
6.84460044197976E-10 |
| Male-vs-Female |
6.759400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.791600E-02 |
| Normal-vs-Age(41-60Yrs) |
5.00360000099676E-08 |
| Normal-vs-Age(61-80Yrs) |
4.21879997603014E-09 |
| Normal-vs-Age(81-100Yrs) |
9.360000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.683000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.440800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.840000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.461800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.591440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.182400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.77850000282476E-08 |
| Normal-vs-Grade 2 |
1.63750124571038E-11 |
| Normal-vs-Grade 3 |
1.08070000004457E-06 |
| Normal-vs-Grade 4 |
1.200270E-02 |
| Grade 1-vs-Grade 2 |
1.056960E-01 |
| Grade 1-vs-Grade 3 |
4.162600E-03 |
| Grade 1-vs-Grade 4 |
2.594000E-01 |
| Grade 2-vs-Grade 3 |
9.321500E-03 |
| Grade 2-vs-Grade 4 |
8.656200E-01 |
| Grade 3-vs-Grade 4 |
3.275200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.74544839587543E-12 |
| Normal-vs-ccB subtype |
1.73253999999901E-05 |
| ccA subtype-vs-ccB subtype |
7.623000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.59139999955649E-07 |
| Normal-vs-N1 |
3.932300E-02 |
| N0-vs-N1 |
5.940400E-01 |
|
|
